Published online Dec 18, 2023. doi: 10.5500/wjt.v13.i6.344
Peer-review started: July 20, 2023
First decision: September 5, 2023
Revised: October 21, 2023
Accepted: November 13, 2023
Article in press: November 13, 2023
Published online: December 18, 2023
Various studies have been done to separately study routine laboratory markers to stratify patients with high risk of morbidity and mortality but very little is known in renal transplant patients.
This study provides a new way of looking at the significance of routine laboratory tests with an aim to risk stratify renal transplant recipients into high-risk sub-groups.
This study will help in shaping new policies and guidelines by providing individualized shielding advice, self-isolation guidance and booster coronavirus disease 2019 vaccination. Moreover, this will also help to plan better follow-up strategies for transplant patient. Addressing and correcting these parameters during a follow-up program can reduce the risk of morbidity and mortality in renal transplant recipients (RTxR).
Retrospective observational study to analyze the data of our renal transplant follow-up program for various routine parameters and their impact of patient outcomes.
This study has identified some routinely used modifiable parameters in predicting a higher risk of mortality and morbidity.
This knowledge can be used in RTxR follow-up programs by addressing these parameters early to help reduce the morbidity and mortality in RTxRs.
This knowledge can be used in RTxR follow-up programs by addressing these parameters early to help reduce the morbidity and mortality in RTxRs.